This Pharma Dividend Has Been Raised Every Single Year for Over a Decade

This Pharma Dividend Has Been Raised Every Single Year for Over a Decade

Key PointsAbbVie has successfully navigated through a major patent cliff, enabling it to sustain a dividend growth streak for more than a decade.Thanks to two strong product portfolios, AbbVie's underlying growth, dividend growth, and share price growth are likely to persist.Poised for further strong growth, consider this stock a strong choice for "buy and hold" investors.10 stocks we like better than AbbVie › AbbVie (NYSE: ABBV), spun off from …